Imperial College London

Professor Sarah Fidler BSc. MBBS. FRCP. PhD

Faculty of MedicineDepartment of Infectious Disease

Professor of HIV and Communicable Diseases
 
 
 
//

Contact

 

+44 (0)20 7594 6230s.fidler

 
 
//

Location

 

clinical trial centre Winston Churchill wingMedical SchoolSt Mary's Campus

//

Summary

 

Awards

  • RIVER study a randomised trial investigating the impact of immediate ART plus vaccine and HDACi on measures of viral reservoir. A proof of concept study, MRC DCS, 2013
  • CHERUB Collabirative HIV eradication UK BRC, BRC, 2012
  • home oral swab sampling to encourage repeat HIV testing, BHIVA, 2011
  • PopART Population effects of antiretroviral therapy to reduce transmission, NIH-Gates HPTN 071, 2011
  • Validation of point of care CD4 test in pregnancy, Imperial BRC, 2011

External Positions

  • member of organising committee, Glasgow HIV Therapy conference organising committee, 2018 - 2020
  • committee representative on behalf of BHIVA, PrEP Policy Group UK, Commissioning of PrEP, 2014
  • Guidelines committee member, British HIV association treatment guidelines committee, BHIVA, 2011
  • committee member, BHIVA scientific and education committee, BHIVA, 2009
  • Steering committee member, UK Register of HIV seroconverter committee, MRC CTU, 2008
  • steering committee member, PIVOT Trial steering committee member, MRC CTU, 2007
  • Advisory Board Member, Towards an HIV Cure Advisory Board and Collaboration GroupStakeholder’s Advisory Board, International AIDS Society

Membership of Professional Bodies

  • British HIV Association co-Chair of research and education committee, British HIV Association, 2016
  • Royal College of Physicians, Fellow, 2013
  • Nominated executive member, British HIV Association, 2005 - 2010
  • BHIVA, BHIVA, 2000
  • Royal College of Physicians, RCP, 1994

Links with Other Academic Bodies

  • HPTN HIV Prevention Trials Network, HPTN is a US NIH funded network of combined HIV prevention trials, 2013
  • Principal investiagtor Consortium HIV AIDS Vaccine initiaitive (CHAVI), Duke University NIH USA, 2005 - 2008

Industrial Connections

  • Pfizer, Clinical collaboration

Editorial Boards

  • HIV Medicine, editorial board member, 2018
  • Viral eradication, editorial board member, 2014 - 2018